Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Immuno-Oncology Congress 2024

Scientific advances in immuno-oncology in 2024: Clinical focus

Augmenting TIL therapy with immune checkpoint blockade

Date

13 Dec 2024

Session

Scientific advances in immuno-oncology in 2024: Clinical focus

Topics

Clinical Research;  Immunotherapy

Tumour Site

Melanoma;  Non-Small Cell Lung Cancer

Presenters

Inge Marie Svane

Authors

I.M. Svane

Author affiliations

  • Herlev Hospital - National Center for Cancer Immune Therapy (CCIT-DK), Herlev/DK

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

From bispecifics to trispecifics

Presenter: Fiona Thistlethwaite

Session: Scientific advances in immuno-oncology in 2024: Clinical focus

Resources:

Slides

Webcast

Q&A and discussion

Session: Scientific advances in immuno-oncology in 2024: Clinical focus

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.